Rafferty Asset Management’s Seres Therapeutics MCRB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-46,819
| Closed | -$2.23M | – | 1089 |
|
|
2023
Q3 | $2.23M | Buy |
46,819
+8,150
| +21% | +$388K | 0.01% | 580 |
|
|
2023
Q2 | $3.7M | Buy |
38,669
+26,705
| +223% | +$2.56M | 0.02% | 482 |
|
|
2023
Q1 | $1.36M | Sell |
11,964
-3,912
| -25% | -$444K | 0.01% | 720 |
|
|
2022
Q4 | $1.78M | Buy |
15,876
+5,646
| +55% | +$632K | 0.01% | 610 |
|
|
2022
Q3 | $1.31M | Buy |
+10,230
| New | +$1.31M | 0.01% | 598 |
|
|
2022
Q2 | – | Sell |
-14,822
| Closed | -$2.11M | – | 1187 |
|
|
2022
Q1 | $2.11M | Sell |
14,822
-1,677
| -10% | -$239K | 0.01% | 589 |
|
|
2021
Q4 | $2.75M | Sell |
16,499
-8,349
| -34% | -$1.39M | 0.01% | 557 |
|
|
2021
Q3 | $3.46M | Buy |
24,848
+18,498
| +291% | +$2.58M | 0.02% | 405 |
|
|
2021
Q2 | $3.03M | Sell |
6,350
-1,446
| -19% | -$690K | 0.02% | 498 |
|
|
2021
Q1 | $3.21M | Buy |
7,796
+5,881
| +307% | +$2.42M | 0.02% | 444 |
|
|
2020
Q4 | $938K | Buy |
+1,915
| New | +$938K | 0.01% | 519 |
|